EHMT2 and cervical cancer: G9A upregulation in breast and cervical cancers was further confirmed using the Genevestigator database [26], which showed an increase in G9A expression in patient cancer tissues and the corresponding cancer cell lines compared to normal breast and cervical tissues respectively (S1 Fig).